MVision AI Segmentation— 510(k) K212915

Substantially Equivalent

MVision AI

FDA 510(k) clearance K212915 for MVision AI Segmentation, Substantially Equivalent on 2022-05-03. Applicant: MVision AI.

Clearance details

Applicant: MVision AI
Product code: Code QKB
Advisory panel: Radiology
Date received: 2021-09-13
Decision date: 2022-05-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Helsinki, FI

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.